This page contains brief information about lutetium Lu 177-dotatate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
atheraLut
FDA Approved
Yes
FDA Approval for Lutetium Lu 177-Dotatate
Use in Cancer
Lutetium Lu 177-dotatate is approved to treat:
- Gastroenteropancreatic neuroendocrine tumors. It is used in adult patients whose cancer is somatostatin receptor positive.
Lutetium Lu 177-dotatate is also being studied in the treatment of other types of cancer.
More About Lutetium Lu 177-Dotatate
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
